HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potential use of poly-N-acetyl-beta-(1,6)-glucosamine as an antigen for diagnosis of staphylococcal orthopedic-prosthesis-related infections.

Abstract
Staphylococcus aureus and coagulase-negative staphylococci are microorganisms most frequently isolated from orthopedic-implant-associated infections. Their capacity to maintain these infections is thought to be related to their ability to form adherent biofilms. Poly-N-acetyl-beta-(1,6)-glucosamine (PNAG) is an important constituent of the extracellular biofilm matrix of staphylococci. In the present study, we explored the possibility of using PNAG as an antigen for detecting antibodies in the blood sera of patients with staphylococcal orthopedic-prosthesis-associated infections. First, we tested the presence of anti-PNAG antibodies in an animal model, in the blood sera of guinea pigs that developed an implant-associated infection caused by biofilm-forming, PNAG-producing strains of Staphylococcus epidermidis. Animals infected with S. epidermidis RP62A showed levels of anti-PNAG immunoglobulin G (IgG) significantly higher than those of the control group. The comparative study of healthy individuals and patients with staphylococcal prosthesis-related infections showed that (i) relatively high levels of anti-PNAG IgG were present in the blood sera of the healthy control group, (ii) the corresponding levels in the infected patients were slightly but not significantly higher, and (iii) only 1 of 10 patients had a level of anti-PNAG IgM significantly higher than that of the control group. In conclusion, the encouraging results obtained in the animal study could not be readily applied for the diagnosis of staphylococcal orthopedic-prosthesis-related infections in humans, and PNAG does not seem to be an appropriate antigen for this purpose. Further studies are necessary to determine whether the developed enzyme-linked immunosorbent assay method could serve as a complementary test in the individual follow-up treatment of such infections caused by PNAG-producing staphylococci.
AuthorsIrina Sadovskaya, Stéphanie Faure, Denis Watier, Damien Leterme, Ali Chokr, Julien Girard, Henry Migaud, Saïd Jabbouri
JournalClinical and vaccine immunology : CVI (Clin Vaccine Immunol) Vol. 14 Issue 12 Pg. 1609-15 (Dec 2007) ISSN: 1556-679X [Electronic] United States
PMID17942607 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Antigens
  • Immunoglobulin G
  • Immunoglobulin M
  • beta-Glucans
  • poly-N-acetyl-1-6-glucosamine
Topics
  • Acetylation
  • Animals
  • Antibodies (blood)
  • Antigens
  • Biofilms (growth & development)
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Guinea Pigs
  • Humans
  • Immunoglobulin G (blood, immunology)
  • Immunoglobulin M (blood, immunology)
  • Models, Animal
  • Prosthesis-Related Infections (diagnosis, microbiology)
  • Staphylococcal Infections (diagnosis, microbiology)
  • Staphylococcus epidermidis (genetics, isolation & purification, metabolism, physiology)
  • Statistics as Topic
  • beta-Glucans (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: